The current price of PSNL is $15.67 — it has decreased by 0.79% since the previous close. Data as of Nov 5, 2026.
PSNL is down 1.51% over the past week, down 4.75% over the past month and up 103.92% over the past year. The price is above its 200-day moving average of $11.38.
Analysts' average 12-month price target for PSNL is $14.95, which implies 4.56% downside from the current price. Individual estimates range from $9.00 to $17.00.
Of the 5 analysts covering Personalis, Inc., 1 rates it a buy and 4 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Personalis, Inc. has a market capitalization of $1.67B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Personalis, Inc. posted a loss of $0.32 per share against an estimate of -$0.2633, missing expectations by 21.52%. Upcoming reports are listed in the earnings calendar.
Personalis, Inc. reported revenue of $25.6M in its most recent quarter, which has increased by 76.59% compared with the same quarter a year earlier. Analysts had expected $21.54M.
Personalis, Inc. has not paid any dividends over the past year.
Companies most comparable to Personalis, Inc. include Natera, Inc., Guardant Health, Inc., GRAIL Inc., BillionToOne, Inc. and Veracyte, Inc.
In the latest trading session PSNL moved between $15.54 and $15.86, a range of 2.01% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Personalis, Inc. shows a sell rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks PSNL has traded between $4.96 and $18.89. The current price is 17.07% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.